Literature DB >> 24733606

MicroRNA-122 overexpression promotes hepatic differentiation of human adipose tissue-derived stem cells.

Nahid Davoodian1, Abbas S Lotfi, Masoud Soleimani, Seyed Javad Mowla.   

Abstract

MicroRNAs are the regulatory molecules in post-transcriptional regulation of gene expression, which affect diverse biological processes and have been found to play important roles in regulating stem cell character in plants and animals. The aim of this study was to identify the role of miR-122 during hepatic differentiation of human adipose tissue-derived stem cells (hADSCs), and also to investigate whether overexpression of miR-122 could enhance differentiation of hADSCs toward functional hepatocyte-like cells without any extrinsic factor. To investigate this, the level of miR-122 was monitored by quantitative real-time PCR (qRT-PCR) at specific time intervals following hepatic differentiation of hADSCs using growth factors. For the next step, lentiviral transduction was applied to overexpress miR-122 in hADSCs for up to 21 days. Hepatic functionality was evaluated by analyzing specific hepatocyte genes and biochemical markers at different time points of differentiation induction. The qRT-PCR results revealed that miR-122 was upregulated during hepatic differentiation of hADSCs. Additionally, the stable miR-122 overexpression in hADSCs resulted in increased expression of specific hepatocyte markers such as ALB, AFP, CK18, CK19, and HNF4a compared with the negative control cells. Moreover, urea and albumin production as well as glycogen deposits were observed in the treated cells. Therefore, our findings demonstrate that the hepatic differentiation process could be improved by the overexpression of miR-122 in hADSCs, making it a potential therapeutic resource for liver disorders.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HEPATIC DIFFERENTIATION; HUMAN ADIPOSE TISSUE-DERIVED STEM CELLS; MicroRNA; miR-122

Mesh:

Substances:

Year:  2014        PMID: 24733606     DOI: 10.1002/jcb.24822

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  21 in total

1.  Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.

Authors:  Indsey Kennedy; Heather Francis; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Liver Res       Date:  2017-04-26

2.  Triple Staining Including FOXA2 Identifies Stem Cell Lineages Undergoing Hepatic and Biliary Differentiation in Cirrhotic Human Liver.

Authors:  Charles E Rogler; Remon Bebawee; Joe Matarlo; Joseph Locker; Nicole Pattamanuch; Sanjeev Gupta; Leslie E Rogler
Journal:  J Histochem Cytochem       Date:  2016-11-24       Impact factor: 2.479

Review 3.  miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir.

Authors:  Sharda Thakral; Kalpana Ghoshal
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

Review 4.  The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases.

Authors:  Christina Nikokiraki; Adriana Psaraki; Maria G Roubelakis
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

5.  Characterization and Classification of Mesenchymal Stem Cells in Several Species Using Surface Markers for Cell Therapy Purposes.

Authors:  Hori Ghaneialvar; Leila Soltani; Hamid Reza Rahmani; Abbas Sahebghadam Lotfi; Masoud Soleimani
Journal:  Indian J Clin Biochem       Date:  2017-02-10

6.  A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.

Authors:  Simone Merlin; Elvira Stefania Cannizzo; Ester Borroni; Valentina Bruscaggin; Piercarla Schinco; Warut Tulalamba; Marinee K Chuah; Valder R Arruda; Thierry VandenDriessche; Maria Prat; Guido Valente; Antonia Follenzi
Journal:  Mol Ther       Date:  2017-05-26       Impact factor: 11.454

7.  Endothelial cell-derived matrix promotes the metabolic functional maturation of hepatocyte via integrin-Src signalling.

Authors:  Xinyue Guo; Weihong Li; Minghui Ma; Xin Lu; Haiyan Zhang
Journal:  J Cell Mol Med       Date:  2017-05-04       Impact factor: 5.310

Review 8.  Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases.

Authors:  Chenxia Hu; Lingfei Zhao; Lanjuan Li
Journal:  J Mol Med (Berl)       Date:  2021-01-02       Impact factor: 4.599

Review 9.  Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.

Authors:  Yuanyuan Jin; Haixia Wang; Ke Yi; Shixian Lv; Hanze Hu; Mingqiang Li; Yu Tao
Journal:  Nanomicro Lett       Date:  2020-11-19

Review 10.  In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  Stem Cells Int       Date:  2015-08-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.